| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.4146 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 58.3674 | 63 |
| GSM780709 | Untreated after 4 days (C3_1) | 70.1585 | 69 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.9118 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 65.5536 | 67 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.3538 | 55 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 71.7257 | 70 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 51.3355 | 52 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 68.2116 | 68 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 75.9349 | 71 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 56.9146 | 62 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 71.0102 | 69 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.9669 | 58 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 70.9598 | 69 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 63.1406 | 66 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 65.2168 | 67 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 70.0536 | 69 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 60.5148 | 65 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.8473 | 59 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 73.8286 | 70 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 82.405 | 72 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 64.5712 | 67 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 68.3547 | 68 |